Omada Research Development from 2010 to 2026

OMDA Stock   11.40  0.25  2.15%   
Omada Health's Research Development is increasing over the years with slightly volatile fluctuation. Research Development is expected to dwindle to about 35.1 M. From 2010 to 2026 Omada Health Research Development quarterly data regression line had arithmetic mean of  28,605,515 and r-squared of  0.51. View All Fundamentals
 
Research Development  
First Reported
2010-12-31
Previous Quarter
41.3 M
Current Value
35.1 M
Quarterly Volatility
4.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Omada Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Omada Health's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 688.3 K or Depreciation And Amortization of 5 M, as well as many indicators such as Price To Sales Ratio of 11.87, Dividend Yield of 0.0 or PTB Ratio of 10.94. Omada financial statements analysis is a perfect complement when working with Omada Health Valuation or Volatility modules.
  
Build AI portfolio with Omada Stock
Check out the analysis of Omada Health Correlation against competitors.
Analyzing Omada Health's Research Development over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Research Development has evolved provides context for assessing Omada Health's current valuation and future prospects.

Latest Omada Health's Research Development Growth Pattern

Below is the plot of the Research Development of Omada Health Common over the last few years. It is Omada Health's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Omada Health's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Omada Research Development Regression Statistics

Arithmetic Mean28,605,515
Geometric Mean28,284,588
Coefficient Of Variation16.61
Mean Deviation3,727,964
Median26,168,000
Standard Deviation4,751,528
Sample Variance22.6T
Range15.1M
R-Value0.71
Mean Square Error11.8T
R-Squared0.51
Significance0
Slope671,908
Total Sum of Squares361.2T

Omada Research Development History

202635.1 M
202541.3 M
202435.9 M
202333.7 M

About Omada Health Financial Statements

Omada Health stakeholders use historical fundamental indicators, such as Omada Health's Research Development, to determine how well the company is positioned to perform in the future. Although Omada Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Omada Health's assets and liabilities are reflected in the revenues and expenses on Omada Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Omada Health Common. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development41.3 M35.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Omada Health Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omada Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omada Health Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omada Health Common Stock:
Check out the analysis of Omada Health Correlation against competitors.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omada Health. Anticipated expansion of Omada directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Omada Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.79)
Revenue Per Share
23.983
Quarterly Revenue Growth
0.566
Understanding Omada Health Common requires distinguishing between market price and book value, where the latter reflects Omada's accounting equity. The concept of intrinsic value - what Omada Health's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Omada Health's price substantially above or below its fundamental value.
It's important to distinguish between Omada Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Omada Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Omada Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.